| |
| |
|
| Insider
Information: |
Simpson Curran |
| Relationship: |
|
| City: |
Rockville |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
123,327 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,696,980 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
123,327 |
|
|
| Total
Value |
$1,696,980 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Human Genome Sciences Inc |
HGSI |
Sr. VP, Operations |
2012-07-30 |
0 |
2007-03-10 |
0 |
Premium* |
|
|
Regenxbio Inc. |
RGNX |
|
2024-01-02 |
123,327 |
2016-12-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
73 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RGNX |
Regenxbio Inc. |
Chief Oper. & Tech. Officer |
• – – |
2021-01-14 |
4 |
AS |
$50.01 |
$580,716 |
D/D |
(11,612) |
17,748 |
0 |
% |
|
| RGNX |
Regenxbio Inc. |
SVP, Product Development & CTO |
• – – |
2020-02-11 |
4 |
AS |
$50.13 |
$634,411 |
D/D |
(12,564) |
3,948 |
0 |
% |
|
| RGNX |
Regenxbio Inc. |
Chief Oper. & Tech. Officer |
• – – |
2021-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
13,800 |
17,748 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Product Development & CTO |
• – – |
2019-12-09 |
4 |
S |
$43.40 |
$680,248 |
D/D |
(15,552) |
23,948 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Sr. VP, Operations |
• – – |
2010-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
16,667 |
27,779 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Product Development & CTO |
• – – |
2019-05-28 |
4 |
OE |
$22.00 |
$396,000 |
D/D |
18,000 |
57,500 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Product Development & CTO |
• – – |
2019-05-28 |
4 |
AS |
$50.00 |
$900,000 |
D/D |
(18,000) |
39,500 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Sr. VP, Operations |
• – – |
2010-06-11 |
4 |
OE |
$9.78 |
$180,549 |
D/D |
18,461 |
43,742 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Sr. VP, Operations |
• – – |
2010-06-11 |
4 |
AS |
$26.07 |
$481,204 |
D/D |
(18,461) |
25,281 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Sr. VP, Operations |
• – – |
2010-08-25 |
4 |
OE |
$9.78 |
$180,549 |
D/D |
18,461 |
43,742 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Sr. VP, Operations |
• – – |
2010-08-25 |
4 |
AS |
$28.00 |
$516,908 |
D/D |
(18,461) |
25,281 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Technical Operations |
• – – |
2017-12-07 |
4 |
OE |
$13.09 |
$464,740 |
D/D |
21,890 |
61,390 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Technical Operations |
• – – |
2017-12-07 |
4 |
AS |
$30.04 |
$657,576 |
D/D |
(21,890) |
39,500 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Sr. VP, Operations |
• – – |
2007-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
22,223 |
22,223 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Sr. VP, Operations |
• – – |
2010-10-01 |
4 |
OE |
$12.56 |
$287,662 |
D/D |
22,903 |
48,184 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Sr. VP, Operations |
• – – |
2010-10-01 |
4 |
AS |
$29.79 |
$682,390 |
D/D |
(22,903) |
25,281 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Sr. VP, Operations |
• – – |
2011-06-01 |
4 |
AS |
$27.11 |
$620,960 |
D/D |
(22,904) |
45,790 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Sr. VP, Operations |
• – – |
2011-06-01 |
4 |
OE |
$12.56 |
$287,674 |
D/D |
22,904 |
68,694 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Sr. VP, Operations |
• – – |
2011-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
24,000 |
45,790 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Technical Operations |
• – – |
2018-03-13 |
4 |
OE |
$22.00 |
$550,000 |
D/D |
25,000 |
64,500 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Technical Operations |
• – – |
2018-03-13 |
4 |
S |
$33.00 |
$825,000 |
D/D |
(25,000) |
39,500 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Sr. VP, Operations |
• • – |
2012-07-30 |
4/A |
D |
$14.25 |
$375,260 |
D/D |
(26,334) |
0 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Sr. VP, Operations |
• – – |
2011-04-29 |
4 |
OE |
$9.78 |
$343,825 |
D/D |
28,015 |
73,805 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Sr. VP, Operations |
• – – |
2011-04-29 |
4 |
AS |
$28.99 |
$812,029 |
D/D |
(28,015) |
45,790 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Sr. VP, Operations |
• – – |
2010-02-16 |
4 |
AS |
$29.10 |
$873,102 |
D/D |
(30,000) |
11,112 |
0 |
- |
|
73 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
